![]() |
市場調査レポート
商品コード
1535101
レゼクトスコープ市場:セグメント別規模、シェア、法規制、償還、手技、設置ベース、2033年までの予測Resectoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 |
||||||
カスタマイズ可能
適宜更新あり
|
レゼクトスコープ市場:セグメント別規模、シェア、法規制、償還、手技、設置ベース、2033年までの予測 |
出版日: 2024年06月26日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
![]() |
レゼクトスコープは、主に子宮、前立腺、膀胱、尿道などの組織の切除や除去に使用される手術器具です。レゼクトスコープは内視鏡の一種で、手術中に手術部位を見るためのカメラと器具を組み合わせた器具です。
泌尿生殖器疾患の有病率の上昇が市場拡大の主な要因です。前立腺肥大症、尿失禁、膀胱がん、その他の子宮内疾患などの疾患は、この成長に寄与する重要なカテゴリーです。
当レポートは、世界のレゼクトスコープ市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、地域、国別の動向などを提供しています。
Resectoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.
A Resectoscope is a surgical instrument primarily used for resection and removal of tissue from the uterus, prostate, bladder, or urethra. A Resectoscope is a type of endoscope, an instrument that combines a camera to allow for viewing of the surgical site during surgery and instrumentation.
The rising prevalence of urogenital diseases is the primary factor fueling market expansion. Conditions such as prostatic hyperplasia, urinary incontinence, bladder cancer, and other intrauterine diseases represent significant categories contributing to this growth.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes and installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Resectoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: KARL STORZ SE & Co KG, Olympus Corp, Richard Wolf GmbH, Stryker Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -